May 19 - May 19
USDA Invests in $100 Million to Combat Highly Pathogenic Avian Influenza
Extramural Funding
USDA has announced plans for a funding opportunity to explore prevention, therapeutics, research and potential vaccine candidates to fight highly pathogenic avian influenza (HPAI). USDA will invest up to $100 million in these projects.
Funding is available, through a competitive process, to for-profit organizations, including manufacturers of vaccines, biologics, and therapeutics, states, universities, livestock producer organizations and other eligible entities. USDA will prioritize proposals that address one or more of the following:
Funding is available, through a competitive process, to for-profit organizations, including manufacturers of vaccines, biologics, and therapeutics, states, universities, livestock producer organizations and other eligible entities. USDA will prioritize proposals that address one or more of the following:
- Development of novel therapeutics and improved diagnostics to address HPAI in poultry.
- Research to further understand risk pathways of avian influenza for producers and to inform improved biosecurity and response strategies.
- Development of novel vaccines to protect poultry from HPAI while promoting biosecurity.